BRICANYL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bricanyl, and when can generic versions of Bricanyl launch?
Bricanyl is a drug marketed by Sanofi Aventis Us and is included in three NDAs.
The generic ingredient in BRICANYL is terbutaline sulfate. There are seven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the terbutaline sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bricanyl
A generic version of BRICANYL was approved as terbutaline sulfate by IMPAX LABS on June 26th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BRICANYL?
- What are the global sales for BRICANYL?
- What is Average Wholesale Price for BRICANYL?
Summary for BRICANYL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 47 |
Clinical Trials: | 9 |
Patent Applications: | 4,068 |
DailyMed Link: | BRICANYL at DailyMed |
Recent Clinical Trials for BRICANYL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Monastir | Phase 1 |
Yaakov Beilin | Phase 2/Phase 3 |
University of Monastir | Phase 3 |
US Patents and Regulatory Information for BRICANYL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | BRICANYL | terbutaline sulfate | AEROSOL, METERED;INHALATION | 018000-001 | Mar 19, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sanofi Aventis Us | BRICANYL | terbutaline sulfate | TABLET;ORAL | 017618-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sanofi Aventis Us | BRICANYL | terbutaline sulfate | INJECTABLE;INJECTION | 017466-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sanofi Aventis Us | BRICANYL | terbutaline sulfate | TABLET;ORAL | 017618-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BRICANYL
International Patents for BRICANYL
See the table below for patents covering BRICANYL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 128491 | ⤷ Sign Up | |
Finland | 54798 | ⤷ Sign Up | |
Italy | 8048168 | ⤷ Sign Up | |
Spain | 361429 | ⤷ Sign Up | |
Netherlands | 7513854 | ⤷ Sign Up | |
Switzerland | 512428 | Verfahren zur Herstellung von neuen 1-(3',5'-Dihydroxy- bzw. -acyloxy-phenyl)-2-aminoäthanolen und deren physiologisch verträglichen Säureadditionssalzen | ⤷ Sign Up |
Spain | 361433 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |